Beyond glycemia: What SGLT2 inhibitors in non-diabetic heart failure really teach us

Cândida Fonseca, Dulce Brito

Open source

DOI: 10.1016/j.repc.2026.08.003
Published: 2026-09
Container: Revista Portuguesa de Cardiologia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.repc.2026.08.003,
  title = {Beyond glycemia: What SGLT2 inhibitors in non-diabetic heart failure really teach us},
  author = {Cândida Fonseca and Dulce Brito},
  year = {2026},
  journal = {Revista Portuguesa de Cardiologia},
  doi = {10.1016/j.repc.2026.08.003},
  url = {https://doi.org/10.1016/j.repc.2026.08.003}
}

RIS

TY  - JOUR
TI  - Beyond glycemia: What SGLT2 inhibitors in non-diabetic heart failure really teach us
AU  - Cândida Fonseca
AU  - Dulce Brito
PY  - 2026
JO  - Revista Portuguesa de Cardiologia
DO  - 10.1016/j.repc.2026.08.003
UR  - https://doi.org/10.1016/j.repc.2026.08.003
ER  -

APA

Fonseca, C., & Brito, D. (2026). Beyond glycemia: What SGLT2 inhibitors in non-diabetic heart failure really teach us. Revista Portuguesa de Cardiologia. https://doi.org/10.1016/j.repc.2026.08.003

Source records

crossref · retrieved 2026-09-26T15:47:25.581Z